SEP 21, 2017 08:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
WEBINAR: Common symptoms and presentations of Multiple Myeloma to primary care physicians
SPONSORED BY: The Binding Site
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
6 10 1835

Speakers:
  • Professor of Medicine & Chief of Multiple Service at Memorial Sloan-Kettering in New York City
    Biography
      Dr. Landgren is Professor of Medicine and Chief Attending Physician of the Myeloma Service at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York, NY. Dr. Landgren is one of the world leaders in the field of early treatment strategies and molecular- and cell-based monitoring of minimal residual disease (MRD) detection in multiple myeloma and its precursor states. He leads a translational research program at MSKCC designed to discover new treatment paradigms integrating modern therapy and novel MRD assays. Dr. Landgren has designed and led the definitive study showing that all multiple myeloma patients are preceded by a precursor stage. As part of his ongoing research program, he is studying molecular mechanisms underlying the trajectory from precursor to full-blown multiple myeloma with the goal to develop of treatment strategies aiming to delay, prevent, and ultimately define a cure for multiple myeloma.

      Dr. Landgren has published over 250 peer-reviewed publications and he is a frequently invited speaker at national and international hematology conferences. He serves on several research committees and editorial boards for scientific journals.

    Abstract:

    DATE: September 21, 2017
    TIME: 8:00AM PST

    Board-certified hematologist-oncologist Ola Landgren, MD, PhD,  will review how vague symptoms (fatigue, bone pain, back pain) are linked to the possibility of underlying Multiple Myeloma and what guideline-recommended tests should be used for diagnosis. Primary care physicians see >50% of Myeloma patients with early symptoms, and early identification and diagnosis are key to starting earlier treatment for Multiple Myeloma patients and preventing secondary complications.

    Learning Objectives:

    • Recognize the symptoms that myeloma patients first present to their Internal Medicine /Family Physician
    • Understand the value of early diagnosis and clinical complications of a delay in diagnosis
    • Identify which lab tests are guideline-recommended for initial testing of myeloma

    Show Resources
    Loading Comments...